Exogenous pigmentation of skin and nail caused by a millipede in a patient with plantar psoriasis
Sign Up to like & getrecommendations! Published in 2018 at "Australasian Journal of Dermatology"
DOI: 10.1111/ajd.12741
Abstract: filled bulla on the left lower abdomen. He had just administered six of his seven injections in his ninth cycle of azacitidine. The lesion on the abdomen corresponded with the site of the azacitidine injection.… read more here.
Keywords: sweet syndrome; azacitidine; pigmentation skin; skin nail ... See more keywords
Impact of FLT3 Mutation on Outcomes after Venetoclax and Azacitidine for Patients with Treatment-Naïve Acute Myeloid Leukemia
Sign Up to like & getrecommendations! Published in 2022 at "Clinical Cancer Research"
DOI: 10.1158/1078-0432.ccr-21-3405
Abstract: Abstract Purpose: To evaluate efficacy and safety of venetoclax + azacitidine among treatment-naïve patients with FLT3-mutant acute myeloid leukemia. Patients and Methods: Data were pooled from patients enrolled in a phase III study (NCT02993523) that… read more here.
Keywords: flt3 mutation; azacitidine patients; acute myeloid; azacitidine ... See more keywords
Azacitidine-associated pleuropericardial effusion in myelodysplastic syndrome: A case report
Sign Up to like & getrecommendations! Published in 2019 at "Journal of Oncology Pharmacy Practice"
DOI: 10.1177/1078155218784762
Abstract: Azacitidine, a deoxyribonucleic acid hypomethylating agent, is used in the treatment of myelodysplastic syndrome. Common adverse effects of azacitidine include bone marrow suppression, injection site reactions, nausea, vomiting, diarrhea, and fatigue. This report focuses on… read more here.
Keywords: azacitidine; myelodysplastic syndrome; report; pleuropericardial effusion ... See more keywords
Azacitidine in Pediatric Hematologic Myeloid Malignancies: A Retrospective Study
Sign Up to like & getrecommendations! Published in 2019 at "Blood"
DOI: 10.1182/blood-2019-131062
Abstract: Purpose: Hypomethylating agents are approved in adults with Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS). By contrast, data in pediatric hematologic malignancies are scarce. Herein, we report the off-label administration of Azacitidine (Aza) in… read more here.
Keywords: azacitidine; treatment; pediatric hematologic; aza ... See more keywords
Cost-effectiveness of azacitidine and venetoclax in unfit patients with previously untreated acute myeloid leukemia.
Sign Up to like & getrecommendations! Published in 2021 at "Blood advances"
DOI: 10.1182/bloodadvances.2020003902
Abstract: The phase 3 VIALE-A trial reported that venetoclax in combination with azacitidine significantly improved response rates and overall survival compared with azacitidine alone in older, unfit patients with previously untreated acute myeloid leukemia (AML). However,… read more here.
Keywords: cost effectiveness; azacitidine; previously untreated; azacitidine venetoclax ... See more keywords
Predictors of the Overall Survival with Azacitidine Monotherapy in Untreated Acute Myeloid Leukemia Patients Ineligible for Intensive Therapy
Sign Up to like & getrecommendations! Published in 2022 at "Internal Medicine"
DOI: 10.2169/internalmedicine.0264-22
Abstract: Objective The prognostic factors for azacitidine in untreated acute myeloid leukemia (AML) patients ineligible for intensive therapy remain unknown. To identify prognostic factors for azacitidine monotherapy and assist clinicians in deciding whether to use azacitidine… read more here.
Keywords: intensive therapy; ineligible intensive; azacitidine monotherapy; patients ineligible ... See more keywords
Higher-dose venetoclax with measurable residual disease-guided azacitidine discontinuation in newly diagnosed acute myeloid leukemia.
Sign Up to like & getrecommendations! Published in 2023 at "Haematologica"
DOI: 10.3324/haematol.2023.282681
Abstract: Venetoclax+azacitidine is the standard of care for newly-diagnosed patients with acute myeloid leukemia (AML) for whom intensive chemotherapy is inappropriate. Efforts to optimize this regimen are necessary. We designed a clinical trial to investigate two… read more here.
Keywords: myeloid leukemia; azacitidine discontinuation; newly diagnosed; acute myeloid ... See more keywords